ARTV MEXC RealStocks
Own real ARTV shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 14:53:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Artiva Biotherapeutics, Inc. (ARTV) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $4.06, with a market capitalization of $200.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.96 to $14.53. This page covers its latest market performance, valuation, price trends and company information.
$200.70M | |
$4.05 | |
$4.10 | |
$4.05 | |
$4.07 | |
64.74K | |
697.87K | |
-- | |
$14.53 | |
$2.96 | |
-- | |
-- |
Artiva Biotherapeutics, Inc. (ARTV) is currently trading at $4.06 as of 2026-11-12 14:51:00, up 0.37% ($0.01) from the previous close of $4.07
During today's regular trading session, ARTV has traded between $4.05 and $4.10, with a trading volume of 64.74K shares. The current price is near the lower end of today's range.
Over the past seven days, Artiva Biotherapeutics, Inc. (ARTV) moved from $4.20 to $4.06, representing a decline of 3.31% ($0.14).
The stock traded between $4.04 and $4.28 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 857.08 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 9.5%
ARTV is currently trading at $4.06, placing it 9.5% of the way from its 52-week low of $2.96 to its 52-week high of $14.53. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 134 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Artiva Biotherapeutics, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Artiva Biotherapeutics, Inc. (ARTV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ARTV, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ARTV shares and USD.
ARTV Shares to USD
1.00 ARTV shares = 4.061 USD
Calculations are estimates based on the latest available price and are for reference only.